HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
ADMA
Adma Biologics Inc
Healthcare Biotechnology · New Jersey, USA · Reports in usd
Market Cap: $2.40B
Market Cap
$2.40B
Enterprise Val
$2.38B
P/E Ratio
16.33
P/B Ratio
5.03
Trailing PEG (1Y)
-0.29
As Of
May 5, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$477.3M
Gross Margin63.82%
Profit Margin63.82%
Return on Equity34.98%
Return on Assets25.98%
Current Ratio6.71
Debt/Equity0.15
LT Debt/Equity0.15
Revenue Per Share0.58

Income Statement

Dec 31, 2025
Revenue$139.2M
Cost of Revenue$50.3M
Gross Profit$88.8M
R&D$1.4M
SG&A$23.5M
Operating Expenses$26.1M
Operating Income$62.8M
Interest Expense$1.6M
Tax Expense$12.2M
Net Income$49.4M
EPS (Basic)$0.21
EPS (Diluted)$0.20
EBIT$63.2M
EBITDA$65.3M
Consolidated Income$49.4M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$87.6M
Accounts Receivable$158.4M
Inventory$206.5M
Current Assets$466.5M
LT Investments$0.00
Property, Plant & Equipment$71.7M
Intangibles$4.2M
Non-Current Assets$157.7M
Total Assets$624.2M
Accounts Payable$22.5M
Current Debt$3.9M
Current Liabilities$69.5M
LT Debt$69.3M
Non-Current Liabilities$77.4M
Total Liabilities$146.9M
Total Debt$73.2M
Retained Earnings-$161.7M
Shareholder Equity$477.3M
Shares Outstanding237,997,765

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$35.6M
Investing Cash Flow-$276.0K
Financing Cash Flow-$9.1M
CapEx-$1.1M
Free Cash Flow$34.6M
Depreciation & Amort.$2.0M
Stock-Based Comp$5.4M
Acquisitions / Disposals$1.0M
Investment Activity$0.00
Debt Issued/Repaid-$482.0K
Equity Issued/Repaid-$8.5M
Dividends Paid$0.00
Net Change in Cash$26.2M
Data cached · Meta live · Daily live · Statements live · TTL 24h